SE436880B - Ergol-8-en- och ergolinforeningar, sett for deras framstellning och farmaceutisk beredning - Google Patents

Ergol-8-en- och ergolinforeningar, sett for deras framstellning och farmaceutisk beredning

Info

Publication number
SE436880B
SE436880B SE8005126A SE8005126A SE436880B SE 436880 B SE436880 B SE 436880B SE 8005126 A SE8005126 A SE 8005126A SE 8005126 A SE8005126 A SE 8005126A SE 436880 B SE436880 B SE 436880B
Authority
SE
Sweden
Prior art keywords
ergol
methyl
methanesulfonyl
acid addition
aminomethyl
Prior art date
Application number
SE8005126A
Other languages
English (en)
Swedish (sv)
Other versions
SE8005126L (sv
Inventor
E Mago
L Toldy
J Borsy
L Tardos
I Kiraly
A Ronay
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE8005126L publication Critical patent/SE8005126L/xx
Publication of SE436880B publication Critical patent/SE436880B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE8005126A 1979-07-12 1980-07-11 Ergol-8-en- och ergolinforeningar, sett for deras framstellning och farmaceutisk beredning SE436880B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79GO1452A HU180467B (en) 1979-07-12 1979-07-12 Process for producing new ergol-8-ene- and ergoline-sceleted compounds

Publications (2)

Publication Number Publication Date
SE8005126L SE8005126L (sv) 1981-01-13
SE436880B true SE436880B (sv) 1985-01-28

Family

ID=10996898

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8005126A SE436880B (sv) 1979-07-12 1980-07-11 Ergol-8-en- och ergolinforeningar, sett for deras framstellning och farmaceutisk beredning

Country Status (19)

Country Link
US (1) US4299836A (fr)
JP (1) JPS5653677A (fr)
AU (1) AU532293B2 (fr)
BE (1) BE884171A (fr)
CA (1) CA1149801A (fr)
CH (1) CH644120A5 (fr)
DE (1) DE3026271A1 (fr)
DK (1) DK160874C (fr)
ES (1) ES8106536A1 (fr)
FR (1) FR2460949A1 (fr)
GB (1) GB2055370B (fr)
HU (1) HU180467B (fr)
IL (1) IL60548A (fr)
IT (1) IT1149840B (fr)
NL (1) NL8004000A (fr)
PH (1) PH16358A (fr)
SE (1) SE436880B (fr)
SU (2) SU1053752A3 (fr)
ZA (1) ZA804198B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2173189B (en) * 1985-02-21 1988-04-27 Maruko Pharmaceutical Co Ergoline derivatives and salts thereof and pharmaceutical compositions thereof
DE3623438C2 (de) * 1986-07-10 1998-04-09 Schering Ag In 2-Stellung mit radioaktivem Iod markierte Ergolinylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Diagnostika
US5242678A (en) * 1986-07-10 1993-09-07 Schering Aktiengesellschaft BR*-diagnostics for monoamine receptors
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL278401A (fr) * 1961-05-29
US3985752A (en) * 1974-12-06 1976-10-12 Eli Lilly And Company 6-Methyl-8-(substituted) methylergolines
IT1064473B (it) * 1976-11-24 1985-02-18 Simes Sulfamoil derivati dell'8-beta-amminometilergolina

Also Published As

Publication number Publication date
SU1072806A3 (ru) 1984-02-07
IL60548A (en) 1983-07-31
HU180467B (en) 1983-03-28
BE884171A (fr) 1981-01-05
IL60548A0 (en) 1980-09-16
CH644120A5 (de) 1984-07-13
DE3026271A1 (de) 1981-02-12
JPH0210834B2 (fr) 1990-03-09
DK160874B (da) 1991-04-29
AU6034980A (en) 1981-01-15
FR2460949A1 (fr) 1981-01-30
US4299836A (en) 1981-11-10
DK300080A (da) 1981-01-13
NL8004000A (nl) 1981-01-14
IT8023387A0 (it) 1980-07-11
AU532293B2 (en) 1983-09-22
ES493335A0 (es) 1981-07-16
FR2460949B1 (fr) 1983-01-21
GB2055370B (en) 1983-05-05
GB2055370A (en) 1981-03-04
PH16358A (en) 1983-09-08
DK160874C (da) 1992-02-24
JPS5653677A (en) 1981-05-13
ZA804198B (en) 1981-07-29
IT1149840B (it) 1986-12-10
CA1149801A (fr) 1983-07-12
SE8005126L (sv) 1981-01-13
DE3026271C2 (fr) 1991-07-25
SU1053752A3 (ru) 1983-11-07
ES8106536A1 (es) 1981-10-16

Similar Documents

Publication Publication Date Title
KR100748150B1 (ko) 무스카린 수용체 길항제 활성을 갖는 요소 화합물
EP0486280A2 (fr) Dérivés de piperidinylcamphresulfonyl comme antagonistes d'oxytocine
SK279109B6 (sk) Imidazolové deriváty s bočným bifenylsulfonylmočov
KR100492052B1 (ko) 인돌-2,3-디온-3-옥심유도체,이의제조방법및이를포함하는약제학적조성물
EP0271795A2 (fr) Dérivés de l'octahydro-10-oxo-6H-pyridazo[1,2-a][112]diazépine, intermédiaires et procédé pour leur préparation ainsi que médicament les contenant
KR20230015333A (ko) 융합된 고리 화합물, 이의 제조 방법, 이의 약제학적 조성물 및 용도
WO2002004459A1 (fr) Modulateurs des proteines tyrosines phosphatases (ptpases)
SE436880B (sv) Ergol-8-en- och ergolinforeningar, sett for deras framstellning och farmaceutisk beredning
EP1392679B1 (fr) Nouveaux derives de 1-amidomethylcarbonyl-piperidine, procede pour produire ces composes et medicaments contenant ces composes
DE3587556T2 (de) 2-Substituierte Aminomethyl-1,4-benzodiazepine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
KR950014866B1 (ko) 에르골리닐 헤테로사이클
EP0240986B1 (fr) Dérivés de D-Nor-7-ergoline, procédé pour leur préparation, composition pharmaceutique et utilisation
HU195810B (en) Process for preparing new 8alpha-acyl-amino-ergoline derivatives and pharmaceutical compositions containing such compounds
Stuetz et al. Ergot alkaloids. 87. New ergolines as selective dopaminergic stimulants
FI68841C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara erotpeptidalkaloidderivat
US4925848A (en) Derivative of codeine useful as an agonist and process for the preparation of it
KR880001280B1 (ko) 2-할로니세르골린 유도체와 그 산부가염의 제조방법
US4235912A (en) Biologically active new 8β-hydrazinomethyl-ergoline derivatives and a process for the preparation thereof
CH619709A5 (en) Process for the preparation of carbamates of 2-halogenoergolines and 2-halogenoergolenes
Bock et al. Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonists
Kline Jr et al. Synthesis of substituted 3-carbamoylecgonine methyl ester analogs: Irreversible and photoaffinity ligands for the cocaine receptor/dopamine transporter
US4753949A (en) 2-chloronicergoline having antihypoxic activity
Galanski et al. Synthesis and pharmacological profile of non-peptide vasopressin antagonists
HU183382B (en) Process for preparing ergoline derivatives and pharmaceutical compositions containing thereof as active substances
KR810002024B1 (ko) 6-n-프로필-8-메톡시메틸 또는 메틸 메르캅토 메틸 에르골린의 제조방법

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8005126-1

Effective date: 19930204

Format of ref document f/p: F